AI
ACHC icon

Axiom Investors’s Acadia Healthcare ACHC Stock Holding History

Axiom Investors’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-68,380
Closed -$5.32M – 138
2023
Q4 		$5.32M Buy
68,380
+53,150
+349% +$3.93M 0.05% 106
2023
Q3 		$1.07M Sell
15,230
-15,624
-51% -$1.17M 0.02% 115
2023
Q2 		$2.46M Sell
30,854
-21,931
-42% -$1.58M 0.04% 98
2023
Q1 		$3.81M Sell
52,785
-106,240
-67% -$8.28M 0.06% 91
2022
Q4 		$13.1M Sell
159,025
-5,315
-3% -$438K 0.26% 59
2022
Q3 		$12.8M Buy
164,340
+51,100
+45% +$4.08M 0.27% 58
2022
Q2 		$7.66M Sell
113,240
-550
-0.5% -$38.4K 0.23% 61
2022
Q1 		$7.46M Buy
113,790
+60,978
+115% +$3.54M 0.18% 66
2021
Q4 		$3.21M Sell
52,812
-37,950
-42% -$2.26M 0.06% 100
2021
Q3 		$5.79M Sell
90,762
-36,078
-28% -$2.28M 0.1% 87
2021
Q2 		$7.96M Sell
126,840
-10,325
-8% -$647K 0.13% 69
2021
Q1 		$7.84M Buy
137,165
+70,780
+107% +$3.83M 0.14% 73
2020
Q4 		$3.34M Buy
+66,385
New +$2.65M 0.05% 104
2016
Q3 		– Sell
-32,076
Closed -$1.78M – 147
2016
Q2 		$1.78M Sell
32,076
-25,401
-44% -$1.49M 0.05% 115
2016
Q1 		$3.17M Sell
57,477
-4,204
-7% -$240K 0.1% 86
2015
Q4 		$3.85M Sell
61,681
-26,824
-30% -$1.75M 0.12% 68
2015
Q3 		$5.87M Buy
88,505
+7,308
+9% +$562K 0.19% 60
2015
Q2 		$6.36M Buy
81,197
+2,070
+3% +$149K 0.18% 65
2015
Q1 		$5.67M Sell
79,127
-24,753
-24% -$1.59M 0.15% 66
2014
Q4 		$6.36M Buy
103,880
+15,430
+17% +$898K 0.16% 69
2014
Q3 		$4.29M Buy
88,450
+28,350
+47% +$1.39M 0.11% 75
2014
Q2 		$2.73M Sell
60,100
-8,500
-12% -$374K 0.06% 92
2014
Q1 		$3.1M Sell
68,600
-2,400
-3% -$118K 0.07% 91
2013
Q4 		$3.36M Buy
71,000
+22,400
+46% +$973K 0.09% 88
2013
Q3 		$1.92M Sell
48,600
-46,400
-49% -$1.72M 0.06% 99
2013
Q2 		$3.14M Buy
+95,000
New +$3.08M 0.11% 78

Other funds holding ACHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axiom Investors's ACHC Position: Q1 2024 in Review

Axiom Investors sold out of Acadia Healthcare (ACHC) in Q1 2024, closing a stake of 68,380 shares — an estimated $5.32M sold.

Axiom Investors first reported a position in ACHC in Q2 2013 and held it in 26 quarters. The position peaked at $13.1M in Q4 2022. 322 funds tracked by Wall St. Rank hold ACHC as of Q1 2024.

  • Axiom Investors reported no remaining Acadia Healthcare position as of Q1 2024 after selling out during the quarter.
  • Axiom Investors sold 68,380 Acadia Healthcare shares in Q1 2024, an estimated $5.32M.
  • Axiom Investors first reported a position in Acadia Healthcare in Q2 2013 and held it in 26 quarters.
  • Axiom Investors's Acadia Healthcare position peaked at $13.1M in Q4 2022.
  • 322 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2024.

Based on Axiom Investors's 13F filing for Q1 2024, filed 13 May 2024.